These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 32306660)
41. EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy. Tang J; Ou J; Xu C; Yi C; Xue F; Xu L; Lai F; Tang J; Li S; Kang T; Ding W; Wang B Oncol Rep; 2017 Oct; 38(4):2251-2258. PubMed ID: 28765910 [TBL] [Abstract][Full Text] [Related]
42. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study. Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736 [TBL] [Abstract][Full Text] [Related]
43. CIP2A is highly expressed in hepatocellular carcinoma and predicts poor prognosis. He H; Wu G; Li W; Cao Y; Liu Y Diagn Mol Pathol; 2012 Sep; 21(3):143-9. PubMed ID: 22847158 [TBL] [Abstract][Full Text] [Related]
44. High expression of TACC2 in hepatocellular carcinoma is associated with poor prognosis. Shakya M; Zhou A; Dai D; Zhong Q; Zhou Z; Zhang Y; Li X; Bholee AK; Chen M Cancer Biomark; 2018; 22(4):611-619. PubMed ID: 29843208 [TBL] [Abstract][Full Text] [Related]
45. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma. Liao W; Huang G; Liao Y; Yang J; Chen Q; Xiao S; Jin J; He S; Wang C Oncotarget; 2014 Nov; 5(21):10271-9. PubMed ID: 25431949 [TBL] [Abstract][Full Text] [Related]
46. Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma. Wu MT; He SY; Chen SL; Li LF; He ZQ; Zhu YY; He X; Chen H BMC Cancer; 2019 Jun; 19(1):538. PubMed ID: 31164099 [TBL] [Abstract][Full Text] [Related]
47. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma. Li B; Shao Q; Ji D; Li F; Guo X; Chen G Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637 [TBL] [Abstract][Full Text] [Related]
48. Increased Expression of Lysine-Specific Demethylase 5B (KDM5B) Promotes Tumor Cell Growth in Hep3B Cells and is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma. Gong J; Yan S; Yu H; Zhang W; Zhang D Med Sci Monit; 2018 Oct; 24():7586-7594. PubMed ID: 30353907 [TBL] [Abstract][Full Text] [Related]
49. A novel multidimensional signature predicts prognosis in hepatocellular carcinoma patients. Wang S; Zhang JH; Wang H; Yang L; Hong S; Yu B; Guo JC; Liu J; Zhu YB J Cell Physiol; 2019 Jul; 234(7):11610-11619. PubMed ID: 30480822 [TBL] [Abstract][Full Text] [Related]
50. Clinical significance of high expression of stanniocalcin-2 in hepatocellular carcinoma. Wang Y; Wu J; Xu J; Lin S Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30962272 [TBL] [Abstract][Full Text] [Related]
51. Overexpression of long noncoding RNA HOXC13-AS and its prognostic significance in hepatocellular carcinoma. Zhou JF; Shi YT; Wang HG; Yang XZ; Wu SN Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7369-7374. PubMed ID: 31539123 [TBL] [Abstract][Full Text] [Related]
52. Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients. Liu C; Zhou N; Li J; Kong J; Guan X; Wang X Dis Markers; 2017; 2017():2176460. PubMed ID: 28684886 [TBL] [Abstract][Full Text] [Related]
53. [Expression of ZNF207 in hepatocellular carcinoma and its significance]. Zhou C; Li N Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 44(4):406-412. PubMed ID: 31113916 [TBL] [Abstract][Full Text] [Related]
54. [Cyclin A1 affects the invasion, metastasis, and prognosis of hepatocellular carcinoma]. Ma YR; Yang Q; Li H; Song JZ; Zhou X; Xiang FG Zhonghua Gan Zang Bing Za Zhi; 2023 Oct; 31(10):1043-1050. PubMed ID: 38016768 [No Abstract] [Full Text] [Related]
55. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1. Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823 [TBL] [Abstract][Full Text] [Related]
56. miR-17-5p as a novel prognostic marker for hepatocellular carcinoma. Chen L; Jiang M; Yuan W; Tang H J Invest Surg; 2012 Jun; 25(3):156-61. PubMed ID: 22583011 [TBL] [Abstract][Full Text] [Related]
57. Accelerated expression of a Myc target gene Mina53 in aggressive hepatocellular carcinoma. Ogasawara S; Komuta M; Nakashima O; Akiba J; Tsuneoka M; Yano H Hepatol Res; 2010 Apr; 40(4):330-6. PubMed ID: 20070393 [TBL] [Abstract][Full Text] [Related]
58. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Xu MZ; Yao TJ; Lee NP; Ng IO; Chan YT; Zender L; Lowe SW; Poon RT; Luk JM Cancer; 2009 Oct; 115(19):4576-85. PubMed ID: 19551889 [TBL] [Abstract][Full Text] [Related]
59. Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study. Wang Y; Huang Q; Deng T; Li BH; Ren XQ Med Sci Monit; 2019 May; 25():3894-3901. PubMed ID: 31128068 [TBL] [Abstract][Full Text] [Related]
60. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma. Hu X; He B; Zhou L; Xie H; Zheng S Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]